Insights On Upstream Manufacturing
-
A Flexible Solution To Automate Concentration, Washing, And Formulation
3/27/2024
Enjoy the flexibility of user-definable parameters, allowing you to tailor each step of your process, including concentration via continuous flow, washing, resuspension, and final formulation.
-
Navigating Challenges In Immune Cell Therapy Analysis
3/27/2024
During this panel, experts discuss the challenges faced by developers and manufacturers in the immune cell therapy field. These challenges include scalability, regulatory hurdles, and data standardization.
-
How Close Are We To The Clinic?
3/27/2024
Organoids are offering new possibilities in therapeutic screening, regenerative medicine, and even organ transplantations. However, there are still several challenges to overcome.
-
AAV Process Intensification Using High Salt Lysis & Salt Tolerant Endonuclease
3/25/2024
Examine how intensifying AAV production with high salt lysis and Benzonase® Salt Tolerant endonuclease enhances viral yield and infectivity while ensuring DNA removal for patient safety.
-
Find The Right T Cell Expansion And Phenotype Balance For Cell Therapy
3/22/2024
Explore this study that works to determine the optimal concentrations of IL-7 and IL-15 for T cell expansion, as well as how to produce the desired phenotype while requiring less protein.
-
Touch-Free T Cell Expansion With A Fill-And-Forget Workflow
3/22/2024
Explore a bioreactor for large-scale, low-cost immune cell therapy manufacturing paired with a "fill-and-forget" workflow and discover how robust T cell expansion can be achieved.
-
A Platform For Stable LVV Production Cell Lines Yield
3/21/2024
LVV manufacturing processes remain a significant hurdle for sponsors. Review the potential of a platform of packaging and producing cell lines designed to enhance LVV manufacturing efficiency.
-
Development And Optimization Of Suspension-Adapted 293T Cell Line
3/21/2024
Learn how an adapted cell line can reduce costs and improve scalability in the production of lentiviral vectors for CGTs and examine its potential to produce GMP-grade lentiviral vectors.
-
Scale Up Strategy For Oncolytic HSV-1 Vector Manufacturing
3/21/2024
Discover how a novel, large-scale production method for herpes simplex virus type-1 vectors has the potential to accelerate the progress of gene therapy and bring it closer to widespread application.
-
Cell Line Development For High-Titer Lentivirus Vector Production
3/21/2024
Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This approach paves the way for more efficient and large-scale production of LV vectors.